Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Telomir Pharmaceuticals, Inc. (TELO) had Current Ratio of 1.94 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-16.53M |
|
-- |
|
-- |
|
$12.24M |
|
$-12.24M |
|
$-4.29M |
|
$-16.53M |
|
$-16.53M |
|
$-16.53M |
|
$-16.53M |
|
$-16.53M |
|
$-16.53M |
|
$-12.24M |
|
$-7.90M |
|
29.54M |
|
29.54M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$1.32M |
|
-- |
|
-- |
|
$1.32M |
|
$0.68M |
|
-- |
|
-- |
|
$0.68M |
|
$0.64M |
|
$0.64M |
|
$0.64M |
|
29.76M |
|
| Cash Flow Statement Financials | |
$-5.07M |
|
-- |
|
$6.34M |
|
$0.00M |
|
$1.27M |
|
$1.26M |
|
$6.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
1.94 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2571.03% |
|
-2571.04% |
|
-1248.69% |
|
-2571.04% |
|
$0.02 |
|
$-0.17 |
|
$-0.17 |
|